# An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

> **NCT01598597** · — · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 276 (actual)

## Conditions studied

- Breast Cancer
- Colorectal Cancer
- Non-Small Cell Lung Cancer
- Glioblastoma
- Renal Cell Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01598597
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 276 (ACTUAL)
- **Last updated:** 2015-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01598597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01598597, "An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01598597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*